Back to 
BARCLAYS PLC
BARCLAYS PLC
COGT
Showing 0 of 7 quarters
Position history for BARCLAYS PLC's holdings in UNUM THERAPEUTICS INC
No. Barclays exited its COGT (Unum Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 7,474 shares worth $3,000. Barclays first reported COGT in Q1 2019 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.